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Haiti and the Dominican Republic, which share the island of Hispaniola, are the last locations in the Caribbean
where malaria still persists. Malaria is an important public health concern in Haiti with 17,094 reported cases in
2014. Further, on January 12, 2010, a record earthquake devastated densely populated areas in Haiti including many
healthcare and laboratory facilities. Weakened infrastructure provided fertile reservoirs for uncontrolled transmission
of infectious pathogens. This situation results in unique challenges for malaria epidemiology and elimination efforts.
To help Haiti achieve its malaria elimination goals by year 2020, the Laboratoire National de Santé Publique and
Henry Ford Health System, in close collaboration with the Direction d’Épidémiologie, de Laboratoire et de
Recherches and the Programme National de Contrôle de la Malaria, hosted a scientific meeting on “Elimination
Strategies for Malaria in Haiti” on January 29-30, 2015 at the National Laboratory in Port-au-Prince, Haiti. The meeting
brought together laboratory personnel, researchers, clinicians, academics, public health professionals, and other
stakeholders to discuss main stakes and perspectives on malaria elimination. Several themes and recommendations
emerged during discussions at this meeting. First, more information and research on malaria transmission in Haiti are
needed including information from active surveillance of cases and vectors. Second, many healthcare personnel need
additional training and critical resources on how to properly identify malaria cases so as to improve accurate and timely
case reporting. Third, it is necessary to continue studies genotyping strains of Plasmodium falciparum in different sites
with active transmission to evaluate for drug resistance and impacts on health. Fourth, elimination strategies outlined
in this report will continue to incorporate use of primaquine in addition to chloroquine and active surveillance of cases.
Elimination of malaria in Haiti will require collaborative multidisciplinary approaches, sound strategic planning, and
strong ownership of strategies by the Haiti Ministère de la Santé Publique et de la Population.
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Haiti and the Dominican Republic, which share the island
of Hispaniola, are the last locations in the Caribbean
where malaria still persists [1]. Malaria is an important
public health concern in Haiti with 17,094 reported cases
in 2014 by the Service de Suivi et d’Evaluation of the
Programme National de Contrôle de la Malaria (PNCM)
(private database); however, it has been estimated that up
to 220,000 cases may be present, with an estimated 80 %* Correspondence: mzervos1@hfhs.org
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In patients presenting to clinics in Haiti with undifferenti-
ated acute febrile illness, 3 to 47 % were malaria positive
[3–12]. The morbidity and economic impact of malaria is
enormous, with infections being both a cause and a result
of poverty [13].
In Haiti, malaria infections have been found to be
predominantly caused by Plasmodium falciparum [1],
but Plasmodium malariae appears sporadically [14].
Anopheles albimanus is the confirmed vector [15], but
Anopheles pseudopunctipennis may also be a potential
vector [16]. Studies in Haiti on the susceptibility of P.
falciparum to chloroquine date back thirty years [17]ticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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malarial is considered to the present day by the Ministère
de la Santé Publique et de la Population (MSPP—Haitian
Ministry of Public Health and Population) as the first-line
drug of choice for treating uncomplicated malaria. Fur-
ther, on January 12, 2010, a record earthquake devastated
densely populated areas in Haiti including many health-
care and laboratory facilities. International aid has sup-
ported reconstruction efforts yet, even now, large densely
populated settlements and weakened infrastructure pro-
vides fertile reservoirs for uncontrolled transmission of in-
fectious pathogens. This situation resulted in unique
challenges for malaria elimination efforts. Air travel be-
tween Haiti and other countries from international aid
agencies, while welcomed, actually offered the potential
for rapid dissemination of novel or drug-resistant malaria.
Knowledge of the origin of novel strains is needed to de-
tect the potential importation of drug resistant strains.
Over the past decade there has been renewed interest in
eliminating malaria from Hispaniola, with a bi-national
agreement recently adopted between the Dominican
Republic and Haiti to eliminate malaria by 2020 [2].
Reported cases of malaria in the Dominican Republic have
reached a 15-year low of 952 cases in 2012; however, 1/3
of these cases were thought to be imported directly from
Haiti [2]. Thus, control of malaria in Haiti will be key to
sustainable malaria elimination for the entire island. How-
ever, current programmes to eliminate malaria in Haiti are
limited by lack of active surveillance of infections.
To help Haiti achieve its malaria elimination goals by
year 2020, the Laboratoire National de Santé Publique
(LNSP) and Henry Ford Health System (HFHS), in close
collaboration with the Direction d’Epidemiologie, de
Laboratoire et de Recherches (DELR) and the Programme
National de Contrôle de la Malaria, hosted a scientific
meeting on “Elimination Strategies for Malaria in Haiti” on
January 29-30, 2015 at the National Laboratory in Port-au-
Prince, Haiti. The meeting was followed by the Forum
Scientifique, hosted by the DELR, which highlighted pre-
sentations on malaria research in Haiti. The meeting
brought together laboratory personnel, researchers, clini-
cians, academics, public health professionals, and other
stakeholders to discuss main stakes and perspectives on
malaria elimination. The two-day meeting included pre-
sentations by representatives from the MSPP, PNCM,
DELR, LNSP, HFHS, University of Florida, and Centers for
Disease Control and Prevention (CDC).
Situational review: malaria on the island of Hispaniola:
current surveillance efforts
Eradication efforts for malaria on the island of Hispaniola
were almost completely successful in the 1960s. The Do-
minican Republic reduced incidence of malaria to 21 casesin 1968, whereas Haiti reduced positive rates from blood
slides to below 1 % despite screening of well over one
million people that same year of a total population of five
million inhabitants. However, the island of Hispaniola re-
ported 33,664 confirmed cases of malaria by P. falciparum
in 2011, of which 4.8 % were in the Dominican Republic
and 95.2 % in Haiti (Henry PJ, personal communication).
Although malaria is considered as one of the 10 principal
causes of death in Haiti, there were only 10 deaths caused
by malaria in the Dominican Republic in 2010.
Both countries engage in current interventions. In the
Dominican Republic, the programme consists of vector
control for prevention, with diagnosis and treatment of
active cases. The Dominican Republic’s current interven-
tions have strengths and weaknesses. Strengths include
testing all suspected cases, communicating each case to
the central level, enhanced surveillance for cases in
high-risk regions and among very exposed populations,
directly observed treatment, targeted activities for vector
control, and a high level of comprehension of the malaria
risk by the population resulting in active participation in
interventions. Weaknesses include limited funding for
low- to medium-risk zones, the passive surveillance
system is not yet automated, and the utilization of micro-
scopes to diagnose cases.
In Haiti, current interventions include measures of
vector control, including notably the distribution of
insecticide-treated nets (ITNs) with the support of The
Global Fund, as well as partners including local NGOs
and the CDC, that also cooperate with the government
to improve surveillance systems and case management.
Strengths of the current interventions in Haiti include:
the recent adoption of rapid diagnostic tests (RDTs) and
the treatment combination of chloroquine plus prima-
quine, as well as entomological studies and larvicide op-
erations conducted as needed, with the involvement of
international partners. Weaknesses include the lack of
training and dissemination of the most recent norms
and the national strategic plan, the communication of
suspected cases rather than confirmed cases, and the
absence of a mechanism to transfer information on
individual cases to the central level and lack of related
feed-back from central to local settings. Further, the
absence of active case detection and absence of dissem-
ination or insufficient information prevents the targeting
of key interventions.
Opportunities exist for interventions in both countries.
For example, the growing political interest and engage-
ment for bi-national collaboration, as well as a new
CDC project at the Haiti— Dominican Republic border
to use a community-testing model, show great prospects.
However, challenges remain, including instability and
migration that are caused by natural disasters, and the
lack of funding.
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Traditionally, microscopy was the only technique recog-
nized by the Haitian Ministère de la Santé Publique et de
la Population for malaria detection. However, after the
January 2010 earthquake, international actors brought
RDTs, and a 2010 survey compared the performance of
several RDTs to microscopy and found good results for
certain brands. Thus, three brands of RDTs were autho-
rized by the Ministry of Health on April 12, 2010: First Re-
sponse, CareStart, and SD Bioline. Currently for year
2015, three techniques are used in Haiti for confirmed
diagnosis of malaria: 1) microscopy, which serves as the
reference test; 2) RDT; and, 3) polymerase chain reaction-
based assays (PCR). However, PCR is used only by the
National Laboratory in the evaluation of certain studies; it
is not used for diagnostic purposes.
In 2014, there were 17,094 reported cases of malaria in
Haiti. Of these, 10,599 or 62 % were identified by mi-
croscopy, whereas 6,495 (38 %) cases were diagnosed by
RDT. The number of cases may be lower as a result of
limitations of testing and issues with case reporting. The
lower number of cases identified by RDT is attributed to
the fact that many institutions in Haiti lack access to the
tests. It is also suspected that there is a percentage of
false positives reported via microscopy, since uninfected
red blood cells may appear to contain a parasite where
staining is poor or the observer is less experienced.
Table 1 displays the distribution of cases of malaria in
Haiti in 2014 by geographic department; Fig. 1 maps the
national sentinel surveillance sites in Haiti. Of these, the
villages with the highest number of cases include: Croix
des Bouquets [Ouest—1,941], Delmas [Ouest—1,481],
Petit-Goave [Ouest—972], Port-au-Prince [Ouest—763],
Dame-Marie [Grande-Anse—641], Gros-Morne [Artibo-
nite—470], Port de Paix [Nord-Ouest—393] and Jeremie
[Grande-Anse—367]. These statistics represent theTable 1 Number of Cases of Malaria in Haiti in 2014 by
Geographic Department
Department Number of cases Percentage
Ouest 8,406 49 %
Grande’Anse 2,143 13 %
Artibonite 1,944 11 %
Sud 1,367 8 %
Nord-Ouest 940 5 %
Nord 936 5 %
Centre 535 3 %
Nord-Est 297 2 %
Sud-Est 367 2 %
Nippes 159 1 %
TOTAL 17,094hospitals or clinics where cases of malaria are confirmed
and reported to the MSPP.
However, there is a flaw in this representation: often,
people come from very far away to receive quality care
at larger hospitals. Thus, these data may be misleading
for elimination strategies, as they do not accurately
represent the locations where the malaria transmission
occurred. For example, the city of Kenscoff in the Ouest
Department reported 25 cases; however, the climate at
this elevation is not consistent with parasite develop-
ment and transmission by the Anopheles mosquito (the
malaria vector); thus, these patients are most likely
contracting malaria in other areas at a lower altitude.
Updated data and field interventions to determine where
the vector resides are essential to target elimination
strategies for malaria in Haiti.
Laboratory diagnosis of malaria
Key to achieving malaria elimination is the proper
laboratory diagnosis of malaria. An ideal test provides
easily interpreted results, quickly, accurately, specifically
and with great sensitivity. Specificity and sensitivity are
of greater importance if the goal of eradication is to be
achieved. The first step of assay selection is to recognize
advantages and limitations of tests conducted. Malaria
microscopy, rapid diagnostic testing and several molecu-
lar methods, that have utility in resource-limited
settings, were reviewed.
The gold standard for malaria diagnosis is microscopic
detection of Plasmodium morphologies [18]. Skilled mi-
croscopists can readily identify infection and differenti-
ate species at concentrations below 100 parasites per
microlitre of blood utilizing both thick and thin blood
smear modalities. Microscopy lends itself as an efficient
tool for calculating parasite densities and determining
the efficacy of therapeutic interventions. One challenge
for microscopy is that as the incidence of malaria cases
decreases, the labor force for detection becomes less
practiced in the ability to detect rare cases. This can be
addressed via a quality assurance programme that includes
a centralized proficiency-testing component; however,
equipment and skilled labour force requirements make
microscopy less viable as the sole diagnostic tool.
The availability of a range of rapid diagnostic tests offers
an attractive alternative to microscopy for the detection of
malaria parasite antigens and enzymes [19]. As a field
diagnostic tool they have several advantages in that they
provide rapid results, can be administered outside of the
health care setting, do not require an expensive equip-
ment infrastructure and are simple to perform and inter-
pret. Disadvantages include vulnerability to temperature
and humidity, varying sensitivities and specificities, diffi-
culty identifying a new infection from an effectively
treated infection and inability to calculate parasite density.
Fig. 1 National Sentinel Surveillance Sites in Haiti
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being a component in a screening and confirmatory test-
ing algorithm in concert with microscopy, particularly in
eradication scenarios.
There are a variety of other molecular testing methods
for malaria that in general increase the sensitivity and
specificity of detection. However, most require special-
ized equipment, reference laboratory availability, and are
technically demanding with unsatisfactory turn-around-
times. Several recently reported techniques with more
satisfactory characteristics for malaria testing are PET-
PCR [20, 21], RNA Hybridization Assay [22], Ligase De-
tection Reaction-Fluorescent Microsphere (LDR-FM)
[23], Loop Mediated Isothermal Amplification (LAMP)
[24] and a malaria biosensor [25]. Reported sensitivities
and specificities are up to 100 % with some having more
advantageous turn-around-times. In particular, the LDR-
FM assay has the advantage of detecting single nucleo-
tide polymorphisms thereby identifying chloroquine and
amodiaquine resistant organisms. The LAMP assay, in
comparison, has several beneficial characteristics. LAMP
is the isothermal amplification of target nucleic acid util-
izing looping primer oligonucleotides. The incorporationof dyes such as SybrGreen or hydoxynaphthol blue allow
for colorimetric detection of amplified product within the
reaction tube. The sensitivity and specificity of this tech-
nique is reported to be 100 %. This tool is of value in that
it reduces PCR contamination, does not require elaborate
equipment other than an isothermal heating unit and has
a relatively rapid turn-around-time. The primary disad-
vantage is the requirement for electrical power.
Malaria testing should be cost effective, sensitive,
specific, have utility for therapeutic monitoring, and
yield similar results whether conducted in the field or
reference laboratory. All testing can be optimized by im-
plementation of quality assurance programmes, encom-
passing pre-analytic, analytic and post-analytic phases of
testing, and application of testing algorithms for screen-
ing and confirmatory testing.
Entomological capacity building for the surveillance of
mosquito vectors
There is an urgent need to increase the entomological re-
search capacity that would enable detailed bioecological
studies on mosquitoes in Haiti to aid in malaria control
efforts. A search of PubMed revealed very few published
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research activities related to this topic. In the available litera-
ture (published and grey literature), only six mosquito spe-
cies are mentioned: An. albimanus, An. pseudopunctipennis,
Anopheles vestitipennis, Anopheles grabhami, Anopheles
crucians, and Anopheles argyritarsis (Lutz C and Okech B,
personal communication). The major malaria vector in Haiti
is An. albimanus, which has been well documented to have
a bite preference for animals over humans. There is a need
to understand in greater detail all other potential malaria
vectors in Haiti as serious discussions commence on malaria
elimination strategies. Entomological studies on vector-
borne diseases in Haiti are hampered by the severely limited
infrastructural capacity, the absence of highly trained ento-
mologists at the masters and doctorate level and, finally, the
limited funding from local and outside agencies.
The University of Florida vector surveillance prog-
ramme activities aim to strengthen the malaria surveil-
lance capability by enhancing the entomology laboratory
capacity in Haiti. The entomological research capacity in
Haiti was launched by University of Florida following a
model from Africa where the President’s Malaria Initia-
tive has invested substantially in entomology infrastruc-
ture by converting shipping containers into movable
insectarium or “insectary in a box”. The “insectary in a
box” facilities were needed to monitor the insecticide
susceptibility of malaria vectors in Africa. Following this
model, with collaboration and support from the LNSP,
the CDC, and the Armed Forces Health Surveillance
Centers Global Emerging Infections Surveillance, the
University of Florida oversaw the building of such an
“insectary in a box” within the compound of the LNSP
with a completion date of September 29, 2014. This
compound also houses the Department of Epidemiology
and Laboratory Research. The insectary has three rooms:
a mosquito species identification room, an adult
mosquito holding chamber with air conditioning and
humidifier, and the larval mosquito room rearing
mosquitoes. Currently the insectary has a colony of An.
albimanus mosquitoes that are being maintained by two
well-trained technicians working in the insectary.
The laboratory is a critical resource for elimination of
malaria in Haiti by serving to support surveillance, re-
search, and intervention work conducted in concert with
the MSPP, University of Florida scientists, U.S. Depart-
ment of Defense, and other collaborating investigators in
studying and preventing insect borne diseases in Haiti.
Since the building of the insectary, University of Florida
and CDC researchers have collaborated with the PNCM
in Haiti to provide training for field mosquito workers in
Haiti. Each of Haiti’s 10 departments has mosquito field
workers who report directly to the PNCM. With a devel-
oped training plan following World Health Organization
training manuals, these field mosquito workers weretrained on sampling strategies, basic mosquito identifica-
tion and storage, and mosquito rearing.
The next steps for utilizing the insectary include initi-
ating mosquito surveillance in concert with Haitian gov-
ernment priorities. This will include insecticide
susceptibility studies to support implementation of wide
scale vector control operations in Haiti, continued train-
ing to increase the number of Haitian mosquito control
scientists, and providing support to other collaborators
and scientists interested in studying and preventing
vector-borne diseases in Haiti.
Genetic diversity of the malaria parasite in Haiti to aid in
elimination efforts
In recent years, certain strains of P. falciparum have
shown the presence of the gene for resistance to chloro-
quine in the Artibonite region [6, 26] as well as in travel-
lers returning from Haiti [27]. Furthermore, recent studies
have shown the presence of the S108N mutation on some
strains of P. falciparum, a mutation that confers some de-
gree of resistance to pyrimethamine [28], as well as the
presence of a Y184F mutation on the pfmdr1 gene of P.
falciparum which has implications on the susceptibility of
the parasite to drugs [29]. It is thus necessary to continue
studies genotyping strains of P. falciparum in different
sites with active transmission in Haiti.
Toward the goal of elimination of malaria in Haiti,
University of Florida investigators are surveying the popu-
lation of P. falciparum to identify drug resistance loci in
the parasite population as a part of a study of the allelic di-
versity of the parasites and the geographic distribution of
that diversity. These studies have employed microsatellite
analyses as well as deep sequencing of the parasite gen-
ome for expanded single nucleotide polymorphism (SNP)
analyses as well as phylogeography. Further, in this work,
a PCR-based method for detecting virtually all blood stage
infections with P. falciparum, even the infections of
asymptomatic carriers, was implemented.
Conclusions from results obtained to date are that of 79
isolates analysed for the chloroquine resistance mutation
(CQR) K76T, none carried this resistance allele. The geo-
graphic distribution of samples tested was heavily centered
in Port-au-Prince and vicinity where over half of the sam-
ples were obtained with the remaining samples coming
from Jacmel, Artibonite, Nippes, and Cap Haitian [29].
With the comparatively small sample size, University of
Florida investigators had only ~50 % chance of identifying
a sample with a resistance locus, if the true prevalence
were 1 %, thus University of Florida investigators are only
able to conclude that the prevalence is low which is con-
sistent with reports of chloroquine resistant malaria in
travelers following the 2010 earthquake [27]. Similarly a
subset of these samples was examined for mutations
N86Y, S1034C, N1042D and D1246Y in pfmdr1, and none
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allele that would enhance resistance to chloroquine or to
mefloquine or amodiaquine [29].
The genetic diversity of 85 Haitian P. falciparum
isolates, with a geographic distribution of origin as
described above, was assayed using 12 microsatellite loci
[30], (Carter et al., personal communication). There was
a low percentage of multiple infections detected affirm-
ing low transmission rates, but a high allelic diversity
was detected. The similar distribution of alleles found in
isolates from Terre Noire, Leogane, and Jacmel suggests
free gene flow between these parasite populations.
Efforts are underway to expand these studies to include
parasite isolates from more remote regions of Haiti and
to expand the examination of allelic diversity to include
SNPs identified through deep sequencing of the genome.
Sampling has been expanded to include parasites from
Grand’ Anse with continuing efforts to obtain isolates
from other remote regions. The allelic diversity within
this set of samples will be compared with that of the
samples previously analysed. Informative SNPs which
allow us to discriminate between the P. falciparum para-
sites found on Haiti from those present in other regions
of the world are being sought, as well as SNPs that
would define isolated subpopulations of parasites present
within Haiti should they be present. Genome sequence
data are being employed to determine the genetic rela-
tionship of P. falciparum isolates from Haiti with those
from around the world as reported by Manske et al.
[31]. These data will allow identification of drug resist-
ance mutations and predisposing genetic factors for the
development of drug resistance in the parasite popula-
tion and provide data on the diversity of genes encoding
potential vaccine antigens should a malaria vaccine
become available.
Initial results, from sequencing the genome (138x cover-
age) of isolate Leo1 derived from a patient in Leogane,
identified more than 20,000 SNPs in coding sequences as
compared to the reference clone 3D7. Of these more than
8,000 were homozygous non-synonymous SNPs. Not
surprisingly these data, when compared by nearest neigh-
bor or principal component analyses with those of the
MalariaGen Project from Africa and Southeast Asia [31],
indicated that this isolate was most closely related to iso-
lates characterized by the MalariaGen Project from West
Africa. Genetic diversity data including both microsatellite
and SNP analyses will inform elimination efforts identify-
ing introduction of parasites from foreign locations and
describing the translocation of parasites within Haiti
should genetic subpopulations be identified.
Critical to elimination efforts will be the detection of
all individuals infected with the parasite, so that they
may be treated. Of all malaria infections, the most diffi-
cult to identify are those in asymptomatic individualswho have no reason to seek medical care. These are
those in the earliest stages of infection and those who
have become persistently infected and who no longer
have obvious symptoms. A recent review has described
the potential for P. falciparum to persist in an asymptom-
atic host for more than a decade [32]. These infections
were either discovered as transfusion or transplant-
transmitted malaria or with the appearance of symptoms
long after leaving a malaria endemic area. Authors of this
review drew the conclusion that is of critical importance
to elimination efforts in Haiti: “Even if only a tiny propor-
tion of untreated or partially treated infections become
indolent, this represents a huge potential reservoir of sus-
tained transmission”.
Removing this threat to elimination efforts will require
treating literally everyone in the population or detecting
and treating those who are asymptomatic carriers. The
surprising number of severely anemic individuals among
children and pregnant women in the rural population
where University of Florida investigators have monitored
for malaria infections may present a concern for use of
primaquine in a mass drug administration strategy, since
up to 20 % of the population is G6PD deficient [33].
Testing will require obtaining a blood sample, allowing
assessment of anemia before administering primaquine,
but successful elimination via diagnosis and treatment
will require an ultrasensitive test that reliably detects
virtually all infected individuals. Reliability of detection
decreases at lower parasitaemia for virtually all tests,
since one or more parasites or the target to be detected
must be in the sample to obtain a positive test result. A
molecular, PCR-based test for the ribosomal RNA of the
parasite promises to be the most sensitive test available
for detecting infected individuals. Using rRNA as the
target overcomes limitations of genomic DNA targets,
since ribosomal RNA molecules are among the most
abundant stable nucleic acid molecules in the cell, esti-
mated to be present at ~10,000 copies per parasite [34].
Thus, lysis of a single parasite in the sample releases
~10,000, freely dispersing targets, which allows testing of
a small fraction of the nucleic acids extracted from a
larger volume of blood, up to 1 ml. Results from the
University of Florida investigators’ laboratory indicate
the ability to routinely detect a single parasite in 1.0 ml of
whole blood using a method very similar to that of Kamau
et al. [35] (El Badry et al., personal communication).
The results of these studies provide critical data
needed to guide and monitor malaria elimination by: 1)
determining accurately the point prevalence of both
symptomatic and asymptomatic infections with P. falcip-
arum in communities across Haiti in times of both peak
malaria transmission and minimal malaria transmission;
2) profiling human populations most likely to have
asymptomatic infections; 3) monitoring changes in allelic
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site populations, if they exist presently or when they
arise during elimination; 5) monitoring changes in point
prevalence during elimination; and 6) monitoring the ap-
pearance and spread of drug resistant haplotypes during
elimination should they emerge.
Plasmodium falciparum gametocyte carriers amongst the
habitants of five departments of the South of Haiti
A study by Raccurt et al. [36] details community surveys
for malaria conducted by the LNSP between May 2010
and October 2013. The surveys were conducted in five
Departments: Ouest, Sud-Est, Nippes, Grande’ Anse and
Sud. Of 5,342 people surveyed, 248 were positive, 170
were carriers of trophozoite forms, and 170 were carriers
of gametocytes. When broken down by age, all levels
had similar percentages of gametocytes (~3.5 %) except
for the group of age 50 or higher, which decreased to
1.9 %. The study also noticed seasonal variations be-
tween the rainy seasons (trophozoites: 4.1 % and game-
tocytes: 2.4 %) and the dry seasons (trophozoites: 9.1 %
and gametocytes: 6.3 %).
The population adhered very strongly to the survey
(only 0.9 % refused). The study found large variations of
indicators by locality: malaria is territorial and seasonal, so
periods of transmission vary. Malaria represents about 5 %
of febrile cases seen in consultation. The higher preva-
lence of malaria in all age groups except for those age 50
and up demonstrates that all ages must be studied, not
just children.
Several recommendations can be made based on the re-
sults of this study. A critique of current official reporting
methods is that cases are reported based on the hospital
where the diagnosis occurred—not where the patient
actually resides (which often is very far away from the
hospital). This biases the statistics which consequently im-
pacts where malaria elimination strategies are targeted.
Thus a better identification mechanism of active house-
holds where transmission occurs is needed. Additionally,
contact between humans and vectors and the dynamics of
transmission must be studied. The control strategies must
be targeted and build on the appropriate results of scien-
tific studies.
Survey of Plasmodium falciparum chloroquine resistant
genotypes Pfcrt in 6 foci of transmission in the South of Haiti
This study surveyed six foci of malaria transmission in
Haiti in the Sud-Est, Ouest, and Grande’ Anse depart-
ments. The finger prick blood specimens of 45 malaria
positive patients were transferred on Whatman filter paper
on three spots for each clinical sample. Filters were air-
dried and stored in individual plastic pouches with a desic-
cant pack at 4° in the dark. Genomic DNA of P. falciparum
was extracted from a 50 mm2 surface of blood-saturatedfilter by soaking the paper in 100 μL of Tris-EDTA buffer.
Filters were incubated at 50 °C for 20 min followed by a
rapid step of mild vortex agitation, heated at 97 °C for
20 min. DNA samples were stored at -20 °C until use.
For the molecular analysis, the polymorphism K76T on
the CRT protein was analysed by restriction fragment
length polymorphism (RFLP) with Apo I enzyme on an
amplicon of the Pfcrt gene. The parasite genomic DNA ex-
tracted from the blood samples was amplified by a nested
PCR. The amplifications were digested with Apo I to verify
the absence of substitution of the lysine residue at position
76 by a threonine giving two bands of 124 and 68 base
pairs long on a 3 % agarose gel electrophoresis. Two clin-
ical samples from Senegal with a known CQ-sensitive and
CQ-resistant phenotype were used as controls.
The 45 positive samples analysed were amplified by
nPCR and analyzed by RFLP. The results showed that all
were digested with Apo I whereas, as expected the Sene-
galese CQ-resistant control was not. The detection of
pfcrt, K76 T mutation responsible of resistance to
chloroquine was negative for all samples tested.
In conclusion, the molecular analysis confirms the
in vivo studies showing the absence of chloroquine resist-
ance among the positive samples harvested in the six foci
of P. falciparum malaria transmission. Further studies are
in progress to detect multidrug resistance gene pfmdr1.
Sociobehavioural barriers to prevention and treatment of
malaria
While various prevention and treatment modalities are
available for malaria, a broad range of factors can affect
utilization of these options. A review of recent literature
suggests barriers at multiple levels including individual,
household, socio-cultural, health infrastructure, and policies
and programmes.
In relation to utilization of ITNs and long-lasting
insecticide-treated nets (LLIN), barriers include: 1) con-
cerns about negative effects of insecticides; 2) feelings of
suffocation when using the net; 3) lack of sufficient nets
to accommodate number of household members and
household sleeping arrangements; 4) perceived lack of
privacy due to net construction; 5) over-washing nets
resulting in decreased efficacy of the insecticide; and, 6)
distrust of the delivery system and associated agencies.
At a logistic level, issues for mobile populations include
challenges with hanging and dismantling the nets. At the
policy and programmes level, barriers include: 1) insuffi-
cient stock and product costs; 2) poor programme delivery
logistics; 3) a need for coordination of efforts between
departments and ministries [37–41].
Barriers to use of intermittent prevention treatment for
pregnant women (IPTp) include: 1) limited knowledge of
malaria-related risks for mother and child; 2) perceptions
of drug safety; 3) poor antenatal care adherence; and, 4)
Table 2 Summary of Recommendations for Malaria Elimination
Strategies in Haiti
Recommendations for Malaria Elimination Strategies in Haiti
Using Combination Therapy with chloroquine and primaquine
to treat suspected and confirmed cases
Using long-lasting insecticidal nets (LLIN) supported by indoor-residual
spraying of insecticide
Strengthening infrastructure
Providing malaria diagnosis and treatment
Timely case detection
Complete and accurate case reporting
Expanding and synchronizing surveillance and data systems
Improving field testing for active case detection
Mapping the location of cases and drug resistance
Mapping the location of G6PD deficiency and prevalence
Evaluating testing limitations
Vector control
Controlling malaria in adjacent communities on the border between
Haiti and the Dominican Republic
Giving intermittent preventative treatment during pregnancy
Utilization of Community Health Workers
Working with partners to build collaborative, multidisciplinary
approaches
Addressing limitations including cost, technical, operational
and financial feasibility
Training and public education
Identification of barriers to implementation and use of prevention and
treatment modalities from perspectives of multiple stakeholders
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lines, distance, and poor healthcare worker-client relation-
ships. Lack of clear healthcare provider guidelines for the
use of IPTp also impacts utilization. At the policy and
programme levels, IPTp use is limited by insufficient stock
and user fees, the need for information about the effect-
iveness of IPTp, and insufficient funding and slow scale-
up of programmes [42–50].
Barriers to diagnosis and treatment of malaria include:
1) use of traditional healers and household treatments; 2)
perceptions of personal vulnerability to malaria particu-
larly in low endemic areas; and 3) logistical issues for
accessing health care. Among healthcare providers, a lack
of familiarity with rapid diagnostic tests and combination
therapies can affect diagnosis and treatment. At the policy
and programmatic level, limitations include inconsistent
RDT supply chains [51–54].
As Haiti moves forward to the elimination of malaria,
relevant lessons from these research data include: 1) the
need for better understanding of the utility of ITN/LLIN
in Haiti in a low-endemic setting; 2) the need for cultur-
ally appropriate community-level and health provider
training and education in regards to prevention and treat-
ment particularly in relation to vulnerable populations
(e.g., pregnant women); 3) the need for long-term educa-
tion to encourage continued use of prevention strategies,
diagnostics and treatment, particularly in low endemic set-
tings; 4) the need for continued programme evaluation
and reviews of programme and policy successes; and 5)
the need for linkage of preventive strategies across vector-
borne diseases (e.g., dengue fever) [55–59].
Organization of epidemiological surveillance in Haiti
The Ministère de la Santé Publique et de la Population
of Haiti created the Direction d’Epidémiologie, de Labor-
atoire et de la Recherche on November 17, 2005. The
mission of the DELR is to guide health action, regulate
the norms and procedures of epidemiological activities,
coordinate the management of information on priority
diseases, and integrate actions of promotion, prevention,
and control of diseases.
The DELR conducts surveillance on transmissible and
non-transmissible diseases at sentinel sites, which must
report certain diseases on either an immediate basis (i.e.
cholera, meningitis, rabies, etc.) or a weekly basis (i.e.
chikungunya, dengue, malaria, breast cancer, etc.). This
mechanism allows the DELR to keep track of: 1) diseases
with a somber prognosis; 2) eradicated diseases, or
diseases on the road to eradication or elimination); 3)
diseases that must be declared at the international level;
and, 4) diseases that are of interest for the national health
system. To be chosen as a sentinel site for this surveil-
lance, the health facility must see at least 400 patients per
month, be accessible, provide a variety of services, havecompetent, trained and motivated personnel, and have ad-
equate technical capacity. A total of 192 sites cover all
geographic areas of Haiti, with an average of one institu-
tion covering 56,967 inhabitants.
Each level has its own responsibilities. At the commu-
nity level, the institution is responsible for identifying
cases and notifying the higher levels. At the geographic
departmental level, the health team is responsible for ana-
lysis, investigation, and reporting. At the national level,
the DELR and MSPP are responsible for training, supervi-
sion and evaluation. With integrated surveillance at the
national level, local response, and the actions of the DELR,
Haiti will have a unified system for conducting epidemio-
logical surveillance.
National control strategy for malaria
A variety of recommendations for strategies can be offered
for malaria elimination in Haiti. These are summarized in
Table 2. Several national initiatives have been created to
specifically address the problem of malaria in Haiti. One
initiative, the Service National pour l’Eradication de la
Malaria (SNEM—the National Service for Eradication of
Malaria) began in 1958 but was closed in 1988. Thus, the
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ated in 2005 and permitted the re-launch of anti-malaria
activities with funding from The Global Fund. The PNCM
is developing a strategic plan for 2016-2022 (Plan Stratégi-
que National d’Elimination de la Malaria—PSNEM) with
a vision of being free of malaria throughout the country
by 2020. A variety of interrelated goals include coordinat-
ing interventions, targeting coastal and low-altitude re-
gions of Haiti, using microscopy or RDTs for all suspected
cases, ensuring that all diagnosed cases of malaria in Haiti
be due only to imported cases, educating 80 % of the
population, and engaging in passive and active surveil-
lance. The 2016-2022 budget is USD $113,412,922.
The future: control and research agenda
The malaria control programme in Haiti is preparing to
move forward from the pre-elimination control phase to
enter into the elimination phase. This will require deter-
mining and implementing a novel elimination plan tai-
lored to Haiti. Some of the critical information needed to
plan, guide, and sustain malaria elimination in Haiti as de-
scribed in a 2013 Clinton Health Access Initiative report
[2] are these:
 Accurately assess the epidemiology of malaria in
Haiti in space and time
 Identify low and high risk areas of transmission
in the country, and quantify the population living
in each
 Consider both vector control and parasite-based
approaches at different levels of coverage and
assess the impact of these interventions to
reach elimination
 Measure the magnitude of malaria parasite
movement on the island and its implications
for the elimination effort
A research agenda for Haiti should include improving
in vitro culture techniques and testing methods; evaluat-
ing drugs to be used for mass drug administration;
evaluating new vector control approaches; using new
collaborative approaches including modeling to evaluate
outcomes of mixed interventions, the role of Commu-
nity Health Workers, and patient provider attitudes; and
strengthening monitoring and evaluation tools that are
embedded in the health and social systems.
The efforts of the authors are invested in pre-
assessment of these parameters and in capacity building in
Haiti to assist in achieving these objectives. Implementa-
tion of proven malaria control measures can reduce trans-
mission everywhere in Haiti where malaria occurs. The
elimination programme will require continued funding for
surveillance and control activities. Recommended activ-
ities include collection of data on prevalence to includeinformation from both passive and active surveillance,
drug resistance and coverage with malaria interventions.
Modelling studies are needed to evaluate persons at risk
and technical feasibility to reduce malaria from its baseline
to very low levels. More information is needed on cover-
age gaps for indoor spraying and ITN effectiveness and
attitudes around use. Information on vector species
present in Haiti, proximity to cases, vector behaviour and
resistance to insecticides is needed. Better information
from active surveillance and surveys are needed on case
detection, diagnosis and treatment and chemoprotection
gaps including pregnant women and children is needed.
Measures using community health workers and better
case management is needed which will reduce the pool of
individuals that can affect others and reduce the number
of individuals at highest risk of mortality. Moving from
control to elimination will require a long timeframe and a
sustained commitment.
Conclusion
Several themes and recommendations emerged during
discussions at this scientific meeting. First, more infor-
mation and research on malaria transmission in Haiti
are needed including information from active surveil-
lance of cases and vectors. Second, many healthcare
personnel and technicians at clinics throughout Haiti
lack adequate training and critical resources on how to
properly identify malaria cases so as to improve accurate
and timely case reporting. Third, it is necessary to con-
tinue studies genotyping strains of P. falciparum in dif-
ferent sites with active transmission to evaluate for drug
resistance and impacts on health. Fourth, elimination
strategies will continue to incorporate use of primaquine
in addition to chloroquine and active case surveillance.
Elimination of malaria in Haiti will require collaborative
multidisciplinary approaches, sound strategic planning,
and strong ownership of the Ministère de la Santé
Publique et de la Population.
The findings in this report demonstrate that Haiti is
continuing to make impressive progress in reducing
malaria cases and deaths. Each year, despite formidable
challenges, more people are being reached with core
malaria interventions, and as a result, more lives are
being saved. The last few years saw a major expansion in
the use of diagnostic testing, the deployment of combin-
ation therapies and improved surveillance systems.
Continued progress is needed in vector identification
and control. The tremendous achievements are the re-
sult of improved and increased commitment, regional
initiatives, and continued international and domestic fi-
nancing. Available funding however remains far less than
what is required to protect everyone at risk. Importantly,
malaria elimination efforts in Haiti will benefit from a
strengthening of health systems. Such investments will
Boncy et al. Malaria Journal  (2015) 14:237 Page 10 of 11help close the disparities in coverage, strengthen disease
surveillance and research, and support the development
and deployment of new tools and approaches. It will
make malaria and other public health responses more
effective and more sustainable. Recent progress in redu-
cing the human suffering caused by malaria in many
countries has shown us that, with adequate investments
and the right combination of strategies, remarkable
strides can indeed be made against this foe. Stakeholders
should act with a shared and focused goal: to create a
Haiti where no one dies of malaria.Abbreviations
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